Vexev raises $6 million for VxWave U.S. commercialization
Vexev raised $6 million, bringing total funding to $19 million, to advance regulatory work, manufacturing scale-up and U.S. commercialization of VxWave.
Evidence notes
- VxWave combines robotics, AI and ultrasound to automate three-dimensional upper-limb vascular imaging, initially for dialysis vascular-access workflows.
- A multisite U.S. Renal Care study achieved a 94% scanning success rate when the investigational system was used by non-specialist staff.
- TreeArc Investment Group, TEN13, Bioshore Ventures and Alumni Ventures joined existing backers including Blackbird Ventures and Neotribe Ventures.
Company context
Vexev develops autonomous robotic ultrasound systems for standardized vascular imaging.